CXCL10 and early-onset autosomal dominant Alzheimer disease: Cerebrospinal fluid of patients with mild Alzheimer’s disease shows higher levels of CXCL10 than healthy individuals (Galimberti et al., 2003), which indicates a role of this molecule at the onset of the disease when there is prominent inflammation.